CECC is in talks with vaccine suppliers to purchase nearly 20 million doses of COVID-19 vaccines and expects to have vaccines as early as March 2021
The Central Epidemic Command Center (CECC) announced that it has negotiated with COVID-19 vaccine manufacturers to procure approximately 20 million doses, including 4.76 million doses through COVAX, and 10 million doses from AstraZeneca, and some doses from another vaccine maker, which is still under discussion. The vaccine doses are expected to be delivered as early as March 2021, and the vaccine cold chain system required has been planned. The CECC is also in talks with several other vaccine manufacturers whose vaccines have entered phase 3 of clinical trials.
- Created：2020-12-30
- Last Updated：2021-03-08
- Count Views：